Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Q2 2022 Earnings Conference Call August 4, 2022 4:30 PM ET Company Participants Ian Clements - CFO Chris Peetz - President and CEO Peter Radovich - COO Pam Vig - Head, R&D Conference Call Participants Jessica Fye - JPMorgan Lili Nsongo - SVB Ed Arce - H.C. Wainright Ryan Deschner - Raymond James Operator Good afternoon. My name is Chris, and I'll be your conference operator today. At this time, I'd like to welcome everyone to the Mirum Q2 2022 Business Update. [Oper ...

Mirum Pharmaceuticals Inc. (NASDAQ:MIRM) Q1 2022 Results Conference Call May 5, 2022 8:30 AM ET Company Participants Chris Peetz - President, CEO Ian Clements - CFO Peter Radovich - COO Pam Vig - Head, R&D Conference Call Participants Ed Arce - H.C. Wainwright Brian Skorney - Baird Nick Lenard - JPMorgan Josh Schimmer - Evercore Rick Bienkowski - SVB Ryan Deschner - Raymond James Yasmeen Rahimi - Piper Sandler Operator Hello, and welcome to the Mirum Pharmaceuticals first quarter business update. My name is ...

Corporate Presentation May 2022 Forward-Looking Statements This presentation contains "forward-looking" statements that are based on our management's beliefs and assumptions and on information currently available to management. Forward-looking statements include all statements other than statements of historical fact contained in this presentation, including information concerning our business strategy, objectives and opportunities. Forward- looking statements are subject to known and unknown risks, uncerta ...

Corporate Presentation March 2022 Forward-Looking Statements This presentation contains "forward-looking" statements that are based on our management's beliefs and assumptions and on information currently available to management. Forward-looking statements include all statements other than statements of historical fact contained in this presentation, including information concerning our business strategy, objectives and opportunities. Forward- looking statements are subject to known and unknown risks, uncer ...

Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Q4 2021 Earnings Conference Call March 9, 2022 4:30 PM ET Corporate Participants | --- | |--------------------------------------------------| | | | Ian Clements - Chief Financial Officer | | Chris Peetz - President, Chief Executive Officer | | Peter Radovich - Chief Operating Officer | | Pamela Vig - Chief Scientific Officer | | Ian Clements - Chief Financial Officer | | Conference Call Participants | | | | Jessica Fye - JPMorgan | | Mani Foroohar - SVB Leerink | | ...

Corporate Presentation February 2022 Forward-Looking Statements This presentation contains "forward-looking" statements that are based on our management's beliefs and assumptions and on information currently available to management. Forward-looking statements include all statements other than statements of historical fact contained in this presentation, including information concerning our business strategy, objectives and opportunities. Forward- looking statements are subject to known and unknown risks, un ...

Corporate Presentation January 2022 Forward-Looking Statements This presentation contains "forward-looking" statements that are based on our management's beliefs and assumptions and on information currently available to management. Forward-looking statements include all statements other than statements of historical fact contained in this presentation, including information concerning our business strategy, objectives and opportunities. Forward- looking statements are subject to known and unknown risks, unc ...

Corporate Presentation November 2021 Forward-Looking Statements This presentation contains "forward-looking" statements that are based on our management's beliefs and assumptions and on information currently available to management. Forward-looking statements include all statements other than statements of historical fact contained in this presentation, including information concerning our business strategy, objectives and opportunities. Forward-looking statements are subject to known and unknown risks, unc ...

Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Q3 2021 Results Earnings Conference Call November 14, 2021 4:30 PM ET Company Participants Ian Clements - Chief Financial Officer Chris Peetz - President, Chief Executive Officer Peter Radovich - Chief Operating Officer Pamela Vig - Chief Scientific Officer Ian Clements - Chief Financial Officer Conference Call Participants Jessica Fye - JPMorgan Mani Foroohar - SVB Leerink Josh Schimmer - Evercore ISI Ed Arce - H.C. Wainwright Dave Amsellem - Piper Sandler Ryan Des ...

Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Q2 2021 Earnings Conference Call August 5, 2021 4:30 PM ET Company Participants Ian Clements - Chief Financial Officer Chris Peetz - President and Chief Executive Officer Peter Radovich - Chief Operating Officer Conference Call Participants Greco Song - SVB Leerink Yasmeen Rahimi - Piper Sandler Thomas Yip - H.C. Wainwright Etzer Darout - Guggenheim Partners Operator Hello, everyone and welcome to the Mirum Pharmaceuticals, Inc. Second Quarter 2021 Business Update. ...